Key facts
- LivsMed’s last known valuation is $920.8M (Dec 2025).
- It has raised $118.0M; the latest was IPO ($92.2M) in Dec 2025.
- Status: Publicly Held.
- ·Watchlist + deal alerts for LivsMed
- ·The full record, as it builds
Funding rounds
No funding rounds for LivsMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LivsMed
Developer of medical instruments designed to help doctors with precision surgery. The company's instruments are based on articulating technology that provides multiple degrees of freedom at the tip of the instrument that is perfectly synchronized with the user's wrist and hand movements, which is mainly used for laparoscopic surgery, enabling surgeons to revolutionize the capabilities of minimally invasive surgery.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2011
- Employees
- 172
- Website
- livsmed.com/
- Ownership
- Publicly Held
LivsMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LivsMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LivsMed in its N-PORT filings yet. We sweep new filings monthly.